PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24752253-0	2014	Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-beta-lactamase-producing Escherichia coli.	Cefepime	52-60	beta-lactamase	Escherichia coli	97-111	
10668589-8	1999	Cefepime was more active against these two species as well as against Amp C producing species, indole-positive Proteae, and Acinetobacter species.	Cefepime	0-8	beta-lactamase	Escherichia coli	70-75	
15155182-0	2004	Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.	Cefepime	56-64	beta-lactamase	Escherichia coli	91-105	
23543257-9	2013	These strains were further tested for AmpC co-production by the AmpC disc test and all these strains were found to be AmpC positive, thus revealing the superior activity of cefepime in detecting ESBLs in the bacteria which co-produced AmpC.	Cefepime	173-181	beta-lactamase	Escherichia coli	38-42	
23543257-9	2013	These strains were further tested for AmpC co-production by the AmpC disc test and all these strains were found to be AmpC positive, thus revealing the superior activity of cefepime in detecting ESBLs in the bacteria which co-produced AmpC.	Cefepime	173-181	beta-lactamase	Escherichia coli	64-68	
23543257-9	2013	These strains were further tested for AmpC co-production by the AmpC disc test and all these strains were found to be AmpC positive, thus revealing the superior activity of cefepime in detecting ESBLs in the bacteria which co-produced AmpC.	Cefepime	173-181	beta-lactamase	Escherichia coli	64-68	
23543257-9	2013	These strains were further tested for AmpC co-production by the AmpC disc test and all these strains were found to be AmpC positive, thus revealing the superior activity of cefepime in detecting ESBLs in the bacteria which co-produced AmpC.	Cefepime	173-181	beta-lactamase	Escherichia coli	64-68	
20130375-9	2009	In the 66 (58.4%) isolates that co-produced AmpC in addition to the ESBL enzymes, cefepime/cefepime-clavulanate Etest strip detected ESBL in an additional 13 (11.4%) isolates as compared to the other ESBL Etest strips.	Cefepime	82-90	beta-lactamase	Escherichia coli	44-48	
10854806-6	2000	Cefepime was the most active agent tested against pathogens with the potential for enzyme-mediated resistance due to Amp C.	Cefepime	0-8	beta-lactamase	Escherichia coli	117-122	
34249771-1	2021	AmpC beta-lactamases hydrolyze all beta-lactams except cefepime and carbapenems.	Cefepime	55-63	beta-lactamase	Escherichia coli	0-4